TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Est. Return
18.15%
This Fund
S&P 500
1 Year Est. Return
+18.15%
AUM
$2.63B
AUM Growth
-$21.2M
(-0.8%)
Holding
190
Top Buys
| 1 | +$47.3M | |
| 2 | +$18.8M | |
| 3 | +$18M | |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$16.7M |
| 5 |
Pfizer
PFE
|
+$13.7M |
Top Sells
| 1 | +$47.2M | |
| 2 | +$24.6M | |
| 3 | +$24M | |
| 4 |
Humana
HUM
|
+$20.2M |
| 5 |
UnitedHealth
UNH
|
+$17.6M |
Sector Composition
| 1 | Healthcare | 96.54% |
| 2 | Real Estate | 2.01% |
| 3 | Industrials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$197B
| $134M | 5.12% |
555,939
+47,263
|
|
||
2
Gilead Sciences
GILD
$180B
| $129M | 4.93% |
1,559,884
+49,444
|
|
||
|
3
Regeneron Pharmaceuticals
REGN
$78.8B
| $118M | 4.48% |
143,053
+22,191
|
|
||
4
Johnson & Johnson
JNJ
$582B
| $112M | 4.26% |
721,779
+82,100
|
|
||
|
5
UnitedHealth
UNH
$256B
| $111M | 4.21% |
234,173
-36,373
|
|
||
6
Vertex Pharmaceuticals
VRTX
$119B
| $104M | 3.96% |
330,343
|
|
||
7
Eli Lilly
LLY
$880B
| $99.2M | 3.78% |
288,917
|
|
||
8
AbbVie
ABBV
$388B
| $81.5M | 3.1% |
511,599
+33,257
|
|
||
9
Illumina
ILMN
$18.2B
| $80.9M | 3.08% |
357,825
+28,908
|
|
||
|
10
Pfizer
PFE
$151B
| $72.4M | 2.76% |
1,775,076
+317,906
|
|
||
11
AstraZeneca
AZN
$295B
| $68.9M | 2.62% |
992,664
-29,591
|
|
||
12
Biogen
BIIB
$26.6B
| $67M | 2.55% |
240,926
+45,496
|
|
||
13
Abbott
ABT
$188B
| $63.2M | 2.41% |
623,855
-69,196
|
|
||
14
Merck
MRK
$286B
| $58.7M | 2.24% |
552,122
|
|
||
15
Thermo Fisher Scientific
TMO
$173B
| $54M | 2.06% |
93,705
|
|
||
16
Elevance Health
ELV
$64.4B
| $52.5M | 2% |
114,070
+99,426
|
|
||
17
Moderna
MRNA
$20.8B
| $49.5M | 1.88% |
322,217
+57,290
|
|
||
18
Cigna
CI
$70.4B
| $46.7M | 1.78% |
182,631
|
|
||
19
Bristol-Myers Squibb
BMY
$120B
| $46M | 1.75% |
663,796
-23,733
|
|
||
|
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
| $45.5M | 1.73% |
224,663
+112,449
|
|
||
21
Sarepta Therapeutics
SRPT
$1.72B
| $39.4M | 1.5% |
285,653
+144,694
|
|
||
22
argenx
ARGX
$43.3B
| $32.9M | 1.25% |
88,310
+4,289
|
|
||
23
Idexx Laboratories
IDXX
$45.7B
| $29.3M | 1.12% |
58,595
-9,470
|
|
||
24
BioMarin Pharmaceuticals
BMRN
$11.3B
| $29.2M | 1.11% |
300,089
+69,299
|
|
||
25
Intuitive Surgical
ISRG
$168B
| $28.8M | 1.1% |
112,680
|
|